IRB Approval

APPROVAL
August 30, 2022
Matthew Farrelly
919-541-6852, x26852
mcf@rti.org
Dear Matthew Farrelly:
On 8/29/2022, the IRB reviewed the following submission:
Type of Review: Initial Study
Title: Increasing Understanding of Digital Advertising:
Hookah Beliefs Survey
Investigator: Matthew Farrelly
IRB ID: STUDY00022093
Funding Source: FDA Ctr Tobacco Products
Customer/Client Name: FDA Ctr Tobacco Products
Project/Proposal Number: 0215534.009
Contract/Grant Number: HHSF223201610032I
IND, IDE, or HDE: None
The IRB approved the study on 8/29/2022. Any changes to the approved study protcol or
documents must be submitted to the IRB as a modification for review and approval prior
to implementation. Within 30 days of study completion, you should request to close the
study in IRB Express. You can submit a modification or study closure by navigating to
the active study and clicking Create Modification / CR.
In conducting this protocol, you are required to follow the requirements listed in the
Investigator Manual (HRP-103), which can be found by navigating to the IRB Library
within the IRB system.
Sincerely,
The RTI Office of Research Protection

Page 1 of 1